冷痛療法市場：製品（OTC（ゲル、クリーム、パッチ、ラップ、パッド）、処方箋（電動、非電動））、用途（筋骨格系、手術後、スポーツ障害）、流通チャネル（病院、小売、E薬局）-2027年までの世界市場予測

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) - Global Forecast to 2027

冷痛療法の世界市場は、2022年の18億米ドルから2027年には24億米ドルに達すると予測され、予測期間中のCAGRは5.1%となります。この市場の成長は、主に関節炎の罹患率の増加と、手頃な価格でコールドペイン製品を... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年6月7日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	240	285	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

冷痛療法の世界市場は、2022年の18億米ドルから2027年には24億米ドルに達すると予測され、予測期間中のCAGRは5.1%となります。この市場の成長は、主に関節炎の罹患率の増加と、手頃な価格でコールドペイン製品を入手できることに起因しています。
「予測期間中の製品別では、OTC製品分野が最も高い成長率を占めています。
冷痛療法市場は、製品によってOTC製品と処方製品bに区分されます。2021年、OTC製品セグメントは、冷たい痛み治療市場で最も高い成長率を占めています。市場の成長は、小売店やオンライン薬局でOTC製品を簡単に入手できることに大きく起因していると考えられます。
"電子薬局部門が最も高いCAGRを占めた"
流通チャネルに基づき、冷痛療法市場は病院薬局、小売薬局、電子薬局に区分されています。2021年には、e-pharmaciessegmentが最も高い成長率を占めました。これは、薬へのアクセスが容易であることに加え、割引が追加されていることに起因しています。
"アジア太平洋地域。最も成長率の高い地域コールドペインセラピー市場"
世界のコールドペインセラピー市場は、北米、欧州、アジア太平洋地域、ラテンアメリカ、中東・アフリカに区分されています。アジア太平洋地域は、関節炎や他の筋骨格系疾患の有病率の上昇と相まって、老年人口の増加などの要因で、予測期間中に最高のCAGRを記録すると予測されています。

このレポートのために行われた主なインタビューは、次のように分類することができます。

- 企業タイプ別Tier 1 - 40%, Tier 2 - 30%, Tier 3 -30
- 役職別Cレベル：27％、Dレベル：18％、その他：55
- 地域別北米：51%、欧州：21%、アジア太平洋：18%、中南米：6%、中東・アフリカ：4
レポート掲載企業リスト

- Beiersdorf AG (ドイツ)
- DJO Global, Inc.（米国）
- 久光製薬株式会社（日本）
- Össur（アイスランド）
- ジョンソン・エンド・ジョンソン (米国)
- ファイザー (米)
- サノフィ (フランス)
- ロート製薬 (日本)
- 3M（米国）
- カーディナル・ヘルス社（米）
- バード・アンド・クローニン（米国）
- コンパスヘルスブランズ（米国）
- ブレッグ社（米国）
- メドライン・インダストリーズ社（米国）
- パフォーマンス・ヘルス社（米国）
- ロムソンズグループオブインダストリー（インド
- Unexo Life Sciences社（インド）
- ポーラ・プロダクツ (アメリカ)
- ラピッドエイド (カナダ)
- ミューラースポーツメディスン（アメリカ）
- ピックソリューション (アメリカ)
- ブルーダー・ヘルスケア・カンパニー (アメリカ)
- ブラウンメッド社 (米国)
- メディチル (オーストラリア)
- サーモテック (米国)
調査対象
本レポートは、世界の冷痛療法市場の詳細な情報を提供しています。製品、用途、流通チャネル、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの会社概要、最近の開発状況、主要な市場戦略とともに、詳細な競合分析も掲載しています。

レポートを購入する主な利点。
本レポートは、冷痛療法市場全体とそのサブセグメントにおける収益数の最も近い概算を提供することで、市場リーダーや新規参入者を支援します。また、利害関係者が競争環境をより良く理解し、より良いビジネスの位置付けと適切な市場参入戦略を立てるための洞察を得るのに役立ちます。本レポートは、利害関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を提供することを可能にします。

ページTOPに戻る

1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY 35
1.3 MARKETS COVERED 35
1.3.1 COLD PAIN THERAPY MARKET 35
1.3.2 YEARS CONSIDERED FOR THE STUDY 36
1.4 CURRENCY 36
1.5 LIMITATIONS 36
1.6 STAKEHOLDERS 37
1.7 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
2.2 RESEARCH APPROACH 39
FIGURE 1 COLD PAIN THERAPY MARKET: RESEARCH DESIGN METHODOLOGY 39
2.2.1 SECONDARY DATA 40
2.2.1.1 Key data from secondary sources 40
2.2.2 PRIMARY DATA 41
2.2.2.1 Primary sources 42
2.2.2.2 Key data from primary sources 42
2.2.2.3 Key industry insights 43
2.2.2.4 Breakdown of primary interviews 43
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (COLD PAIN THERAPY MARKET) 43
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 44
2.3 MARKET SIZE ESTIMATION 44
2.3.1 BOTTOM-UP APPROACH 45
2.3.1.1 Approach 1: Company revenue estimation approach 45
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 45
2.3.1.2 Approach 2: Presentations of companies and primary interviews 45
2.3.1.3 Growth forecast 46
2.3.1.4 CAGR projections 46
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 46
2.3.2 TOP-DOWN APPROACH 46
FIGURE 6 COLD PAIN THERAPY MARKET: TOP-DOWN APPROACH 47
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 48
FIGURE 7 DATA TRIANGULATION METHODOLOGY 48
2.5 MARKET SHARE 48
2.6 ASSUMPTIONS FOR THE STUDY 49
2.7 LIMITATIONS 49
2.8 RISK ASSESSMENT 50
2.8.1 RISK ASSESSMENT: COLD PAIN THERAPY MARKET 50
2.9 GROWTH RATE ASSUMPTIONS 50
3 EXECUTIVE SUMMARY 51
FIGURE 8 COLD PAIN THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 51
FIGURE 9 COLD PAIN THERAPY MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 52
FIGURE 10 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2022 VS. 2027 (USD MILLION) 52
FIGURE 11 COLD PAIN THERAPY MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 53
4 PREMIUM INSIGHTS 54
4.1 COLD PAIN THERAPY MARKET OVERVIEW 54
FIGURE 12 GROWING PREVALENCE OF MUSCULOSKELETAL CONDITIONS AND INCREASING PARTICIPATION IN SPORTS TO DRIVE MARKET GROWTH 54
4.2 COLD PAIN THERAPY MARKET SHARE, BY PRODUCT, 2022 VS. 2027 55
FIGURE 13 OTC PRODUCTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2027 55
4.3 COLD PAIN THERAPY MARKET SHARE, BY APPLICATION, 2022 VS. 2027 55
FIGURE 14 MUSCULOSKELETAL DISORDERS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 55
4.4 COLD PAIN THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 56
FIGURE 15 RETAIL PHARMACIES SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2027 56
4.5 COLD PAIN THERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE COLD PAIN THERAPY MARKET DURING THE FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 17 COLD PAIN THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Increasing incidence of sports injuries and rising emphasis on exercise and gym activities 58
5.2.1.2 Growing number of hip and knee surgeries across the globe 58
5.2.1.3 Rising geriatric population and subsequent growth in the prevalence of bone diseases and trauma injuries 59
5.2.1.4 Growing need for safer pain management modalities as opposed to oral drug therapy 59
5.2.1.5 Clinical evidence in favor of menthol-based topical analgesics 60
5.2.2 RESTRAINTS 60
5.2.2.1 Wide use of low-priced analgesic pills for immediate pain relief 60
5.2.2.2 Lack of substantial clinical evidence and reimbursement in favor of cold pain therapy 61
5.2.2.3 Health hazards and discomfort associated with cold pain therapy products 61
5.2.3 OPPORTUNITIES 62
5.2.3.1 Growing adoption of analgesic patches 62
5.2.3.2 Growing use of cold pain therapy among middle-aged women 62
5.2.3.3 Increasing regulatory barriers for oral pain medications 63
5.2.4 CHALLENGES 63
5.2.4.1 Availability of alternative non-drug/device pain management therapies 63
5.2.5 IMPACT OF COVID-19 ON THE COLD PAIN THERAPY MARKET 64
5.3 PRICING ANALYSIS 65
TABLE 1 AVERAGE SELLING PRICE OF COLD PAIN THERAPY PRODUCTS (2022) 65
5.4 PATENT ANALYSIS 66
FIGURE 18 PATENT ANALYSIS FOR MOTORIZED COLD PAIN THERAPY DEVICES 66
TABLE 2 LIST OF KEY PATENTS 67
5.5 VALUE CHAIN ANALYSIS 68
FIGURE 19 VALUE CHAIN ANALYSIS OF THE COLD PAIN THERAPY MARKET: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 68
5.6 SUPPLY CHAIN ANALYSIS 69
FIGURE 20 COLD PAIN THERAPY MARKET: SUPPLY CHAIN ANALYSIS 70
5.7 ECOSYSTEM/MARKET MAP 70
FIGURE 21 COLD PAIN THERAPY MARKET: ECOSYSTEM/MARKET MAP 70
TABLE 3 COLD PAIN THERAPY MARKET: ROLE IN ECOSYSTEM 71
5.8 PORTER’S FIVE FORCES ANALYSIS 71
TABLE 4 COLD PAIN THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 71
5.8.1 THREAT OF NEW ENTRANTS 72
5.8.2 THREAT OF SUBSTITUTES 72
5.8.3 BARGAINING POWER OF BUYERS 72
5.8.4 BARGAINING POWER OF SUPPLIERS 72
5.8.5 DEGREE OF COMPETITION 72
5.9 REGULATORY LANDSCAPE 73
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 8 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
5.9.1 NORTH AMERICA 75
5.9.1.1 US 75
5.9.1.2 Canada 75
5.9.2 EUROPE 75
5.9.3 ASIA PACIFIC 76
5.9.3.1 Japan 76
5.9.3.2 India 76
5.9.4 LATIN AMERICA 76
5.9.4.1 Brazil 76
5.9.4.2 Mexico 77
5.9.5 MIDDLE EAST 77
5.9.6 AFRICA 77
5.10 TRADE ANALYSIS 78
5.10.1 TRADE ANALYSIS FOR COLD PAIN THERAPY PRODUCTS 78
TABLE 10 IMPORT DATA FOR ARTICLES AND EQUIPMENT FOR SPORTS AND OUTDOOR GAMES, BY COUNTRY, 2017–2021 (USD MILLION) 78
TABLE 11 EXPORT DATA FOR ARTICLES AND EQUIPMENT FOR SPORTS AND OUTDOOR GAMES, BY COUNTRY, 2017–2021 (USD MILLION) 79
5.11 TECHNOLOGY ANALYSIS 79
5.12 KEY CONFERENCES & EVENTS IN 2022–2023 80
TABLE 12 COLD PAIN THERAPY MARKET: DETAILED LIST OF CONFERENCES & EVENTS 80
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
5.13.1 REVENUE SOURCES ARE SHIFTING TOWARD SAFER PAIN MANAGEMENT DUE TO THE COVID-19 PANDEMIC 81
FIGURE 22 REVENUE SHIFT IN THE COLD PAIN THERAPY MARKET 81
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 82
5.14.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 82
FIGURE 23 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF COLD PAIN THERAPY PRODUCTS 82
TABLE 13 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF COLD PAIN THERAPY PRODUCTS 82
5.14.2 BUYING CRITERIA 83
FIGURE 24 KEY BUYING CRITERIA FOR COLD PAIN THERAPY PRODUCTS 83
TABLE 14 KEY BUYING CRITERIA FOR COLD PAIN THERAPY PRODUCTS 83
5.15 CASE STUDIES 84
5.15.1 CASE STUDY 1 84
6 COLD PAIN THERAPY MARKET, BY PRODUCT 85
6.1 INTRODUCTION 86
TABLE 15 COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 86
6.2 OTC PRODUCTS 86
TABLE 16 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 87
TABLE 17 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
TABLE 18 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 87
TABLE 19 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY REGION,
2020–2027 (USD MILLION) 88
6.2.1 OTC PHARMACEUTICALS 88
TABLE 20 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY TYPE,
2020–2027 (USD MILLION) 88
TABLE 21 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89
TABLE 22 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 89
TABLE 23 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY REGION,
2020–2027 (USD MILLION) 90
6.2.1.1 Gels, ointments, and creams 90
6.2.1.1.1 Gels, ointments, and creams offer effective orthopedic pain management 90
TABLE 24 KEY GELS, OINTMENTS, AND CREAMS AVAILABLE IN THE MARKET 91
TABLE 25 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS,
BY REGION, 2020–2027 (USD MILLION) 91
TABLE 26 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS,
BY APPLICATION, 2020–2027 (USD MILLION) 92
TABLE 27 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 92
6.2.1.2 Sprays and foams 92
6.2.1.2.1 Procedural benefits offered by sprays and foams to increase their adoption among sportspersons 92
TABLE 28 KEY SPRAYS AND FOAMS AVAILABLE IN THE MARKET 93
TABLE 29 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY REGION,
2020–2027 (USD MILLION) 93
TABLE 30 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY APPLICATION, 2020–2027 (USD MILLION) 94
TABLE 31 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 94
6.2.1.3 Patches 94
6.2.1.3.1 Ability to deliver consistent dosage of drugs over topical creams resulting in the greater consumption of cold pain patches 94
TABLE 32 KEY PATCHES AVAILABLE IN THE MARKET 95
TABLE 33 COLD PAIN THERAPY MARKET FOR PATCHES, BY REGION,
2020–2027 (USD MILLION) 96
TABLE 34 COLD PAIN THERAPY MARKET FOR PATCHES, BY APPLICATION,
2020–2027 (USD MILLION) 96
TABLE 35 COLD PAIN THERAPY MARKET FOR PATCHES, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 97
6.2.1.4 Roll-ons 97
6.2.1.4.1 Inconsistent drug delivery and the need for repetitive use on skin are expected to hamper the adoption of roll-ons 97
TABLE 36 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY REGION,
2020–2027 (USD MILLION) 97
TABLE 37 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY APPLICATION,
2020–2027 (USD MILLION) 98
TABLE 38 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 98
6.2.2 OTC MEDICAL DEVICES 98
TABLE 39 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 99
TABLE 40 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 99
TABLE 41 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 100
TABLE 42 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 100
6.2.2.1 Cold packs 100
6.2.2.1.1 Cold packs are among the widely used cold pain therapy medical devices 100
TABLE 43 KEY COLD PACKS AVAILABLE IN THE MARKET 101
TABLE 44 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY REGION,
2020–2027 (USD MILLION) 101
TABLE 45 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY APPLICATION,
2020–2027 (USD MILLION) 102
TABLE 46 COLD PAIN THERAPY MARKET FOR COLD PACKS,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 102
6.2.2.2 Cooling towels, compresses, wraps, and pads 102
6.2.2.2.1 Growing availability of wraps and cooling pads to aid
the growth of this market segment 102
TABLE 47 KEY COOLING TOWELS, COMPRESSES, WRAPS, AND PADS AVAILABLE IN
THE MARKET 103
TABLE 48 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 49 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY APPLICATION, 2020–2027 (USD MILLION) 104
TABLE 50 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 105
6.3 PRESCRIPTION PRODUCTS 105
TABLE 51 KEY PRESCRIPTION PRODUCTS AVAILABLE IN THE MARKET 105
TABLE 52 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 106
TABLE 53 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106
TABLE 54 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 107
TABLE 55 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION) 107
6.3.1 MOTORIZED DEVICES 107
6.3.1.1 Preference for motorized devices is increasing among patients 107
TABLE 56 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY REGION,
2020–2027 (USD MILLION) 108
TABLE 57 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY APPLICATION, 2020–2027 (USD MILLION) 108
TABLE 58 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 109
6.3.2 NON-MOTORIZED DEVICES 109
6.3.2.1 Non-motorized devices cost lower as compared to motorized devices 109
TABLE 59 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY REGION, 2020–2027 (USD MILLION) 110
TABLE 60 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES,
BY APPLICATION, 2020–2027 (USD MILLION) 110
TABLE 61 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 111
7 COLD PAIN THERAPY MARKET, BY APPLICATION 112
7.1 INTRODUCTION 113
TABLE 62 COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113
7.2 MUSCULOSKELETAL DISORDERS 113
7.2.1 INCREASING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 113
TABLE 63 COLD PAIN THERAPY MARKET FOR MUSCULOSKELETAL DISORDERS,
BY REGION, 2020–2027 (USD MILLION) 114
7.3 POST-OPERATIVE THERAPY 114
7.3.1 INCREASING NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES TO DRIVE SEGMENT GROWTH 114
TABLE 64 COLD PAIN THERAPY MARKET FOR POST-OPERATIVE THERAPY, BY REGION, 2020–2027 (USD MILLION) 115
7.4 POST-TRAUMA THERAPY 116
7.4.1 INCREASING INCIDENCE OF TRAUMA INJURIES TO PROPEL SEGMENT GROWTH 116
TABLE 65 COLD PAIN THERAPY MARKET FOR POST-TRAUMA THERAPY, BY REGION, 2020–2027 (USD MILLION) 116
7.5 SPORTS INJURIES 117
7.5.1 INCREASING NUMBER OF SPORTS INJURIES TO DRIVE SEGMENT GROWTH 117
TABLE 66 COLD PAIN THERAPY MARKET FOR SPORTS INJURIES, BY REGION,
2020–2027 (USD MILLION) 117
8 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL 118
8.1 INTRODUCTION 119
TABLE 67 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 119
8.2 RETAIL PHARMACIES 119
8.2.1 RETAIL PHARMACIES FORM THE LARGEST DISTRIBUTION CHANNEL FOR COLD PAIN THERAPY PRODUCTS 119
TABLE 68 COLD PAIN THERAPY MARKET FOR RETAIL PHARMACIES, BY REGION,
2020–2027 (USD MILLION) 120
8.3 HOSPITAL PHARMACIES 120
8.3.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE SEGMENT GROWTH 120
TABLE 69 COLD PAIN THERAPY MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2020–2027 (USD MILLION) 121
8.4 E-PHARMACIES 121
8.4.1 E-PHARMACIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 121
TABLE 70 COLD PAIN THERAPY MARKET FOR E-PHARMACIES, BY REGION,
2020–2027 (USD MILLION) 122
9 COLD PAIN THERAPY MARKET, BY REGION 123
9.1 INTRODUCTION 124
TABLE 71 COLD PAIN THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION) 124
9.2 NORTH AMERICA 124
FIGURE 25 NORTH AMERICA: COLD PAIN THERAPY MARKET SNAPSHOT 125
TABLE 72 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 126
TABLE 73 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 126
TABLE 74 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 126
TABLE 75 NORTH AMERICA: COLD PAIN THERAPY MARKET,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 127
9.2.1 US 127
9.2.1.1 Strong presence of key companies has driven market growth in
the US 127
TABLE 76 US: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 128
TABLE 77 US: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 128
TABLE 78 US: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 79 US: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 80 US: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 81 US: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 129
TABLE 82 US: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 130
9.2.2 CANADA 130
9.2.2.1 Market growth is driven by the rising number of hip and knee replacement surgeries 130
TABLE 83 CANADA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 131
TABLE 84 CANADA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 85 CANADA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 86 CANADA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 87 CANADA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 88 CANADA: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 132
TABLE 89 CANADA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 133
9.3 EUROPE 133
TABLE 90 EUROPE: COLD PAIN THERAPY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 134
TABLE 91 EUROPE: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 134
TABLE 92 EUROPE: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 93 EUROPE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 135
9.3.1 GERMANY 135
9.3.1.1 Increasing healthcare expenditure to drive market growth in Germany 135
TABLE 94 GERMANY: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 136
TABLE 95 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 96 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 97 GERMANY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 98 GERMANY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 99 GERMANY: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 138
TABLE 100 GERMANY: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 138
9.3.2 UK 138
9.3.2.1 Market growth in the UK is mainly driven by the increasing prevalence of musculoskeletal conditions 138
TABLE 101 UK: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 139
TABLE 102 UK: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 139
TABLE 103 UK: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 104 UK: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 105 UK: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 106 UK: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 141
TABLE 107 UK: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 141
9.3.3 FRANCE 141
9.3.3.1 Increasing target patient population to drive market growth in France 141
TABLE 108 FRANCE: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 142
TABLE 109 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 142
TABLE 110 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 111 FRANCE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 112 FRANCE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 FRANCE: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 144
TABLE 114 FRANCE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 144
9.3.4 ITALY 144
9.3.4.1 Growing public awareness about the preventive care of musculoskeletal disorders to drive market growth 144
TABLE 115 ITALY: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 145
TABLE 116 ITALY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 145
TABLE 117 ITALY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 118 ITALY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 119 ITALY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ITALY: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 147
TABLE 121 ITALY: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 147
9.3.5 SPAIN 147
9.3.5.1 Increasing prevalence of target diseases to drive market growth 147
TABLE 122 SPAIN: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 148
TABLE 123 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 148
TABLE 124 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 SPAIN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 126 SPAIN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 127 SPAIN: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 150
TABLE 128 SPAIN: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 150
9.3.6 REST OF EUROPE 150
TABLE 129 NUMBER OF SURGERIES CONDUCTED IN ROE COUNTRIES 151
TABLE 130 ROE: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 151
TABLE 131 ROE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 151
TABLE 132 ROE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 133 ROE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 134 ROE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 135 ROE: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 153
TABLE 136 ROE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 153
9.4 ASIA PACIFIC 154
FIGURE 26 APAC: COLD PAIN THERAPY MARKET SNAPSHOT 155
TABLE 137 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 156
TABLE 138 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 156
TABLE 139 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 157
TABLE 140 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 157
9.4.1 JAPAN 157
9.4.1.1 Increasing geriatric population to drive market growth in Japan 157
TABLE 141 JAPAN: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 146 JAPAN: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 160
TABLE 147 JAPAN: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 160
9.4.2 CHINA 160
9.4.2.1 Expansion in the target patient population to drive market growth 160
TABLE 148 CHINA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 161
TABLE 149 CHINA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 CHINA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 151 CHINA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 CHINA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 153 CHINA: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 163
TABLE 154 CHINA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 163
9.4.3 INDIA 163
9.4.3.1 Growing number of arthritis cases to drive market growth 163
TABLE 155 INDIA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 164
TABLE 156 INDIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 157 INDIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 158 INDIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 159 INDIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 160 INDIA: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 166
TABLE 161 INDIA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 166
9.4.4 AUSTRALIA 166
9.4.4.1 Rising prevalence of target diseases to drive market growth 166
TABLE 162 AUSTRALIA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 167
TABLE 163 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 164 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 165 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 166 AUSTRALIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 167 AUSTRALIA: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 169
TABLE 168 AUSTRALIA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 169
9.4.5 SOUTH KOREA 169
9.4.5.1 Supportive government initiatives are expected to positively impact market growth 169
TABLE 169 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 170
TABLE 170 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 171 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 172 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 173 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 174 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 171
TABLE 175 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 172
9.4.6 REST OF ASIA PACIFIC 172
TABLE 176 ROAPAC: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 173
TABLE 177 ROAPAC: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 178 ROAPAC: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 179 ROAPAC: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 180 ROAPAC: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 181 ROAPAC: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 174
TABLE 182 ROAPAC: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 175
9.5 LATIN AMERICA 175
TABLE 183 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 175
TABLE 184 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 176
TABLE 185 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 176
TABLE 186 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 176
9.5.1 BRAZIL 177
9.5.1.1 Growing obese population will drive market growth in Brazil 177
TABLE 187 BRAZIL: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 177
TABLE 188 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 177
TABLE 189 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 190 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 191 BRAZIL: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 192 BRAZIL: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 179
TABLE 193 BRAZIL: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 179
9.5.2 MEXICO 179
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 179
TABLE 194 MEXICO: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 180
TABLE 195 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 180
TABLE 196 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 197 MEXICO: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 198 MEXICO: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 199 MEXICO: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 182
TABLE 200 MEXICO: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2020–2027 (USD MILLION) 182
9.5.3 REST OF LATIN AMERICA 182
TABLE 201 ROLATAM: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 183
TABLE 202 ROLATAM: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 203 ROLATAM: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS,
BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 204 ROLATAM: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES,
BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 205 ROLATAM: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 206 ROLATAM: COLD PAIN THERAPY MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 184
TABLE 207 ROLATAM: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 185
9.6 MIDDLE EAST & AFRICA 185
TABLE 208 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 185
TABLE 209 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 186
TABLE 210 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET,
BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 186

10 COMPETITIVE LANDSCAPE 187
10.1 OVERVIEW 187
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 187
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE COLD PAIN THERAPY MARKET 188
TABLE 211 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COLD PAIN THERAPY PRODUCT MANUFACTURING COMPANIES 188
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 189
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE COLD PAIN THERAPY MARKET 189
10.4 MARKET SHARE ANALYSIS 190
10.4.1 COLD PAIN THERAPY MARKET 190
FIGURE 28 COLD PAIN THERAPY MARKET SHARE, BY KEY PLAYER (2021) 190
TABLE 212 COLD PAIN THERAPY MARKET: DEGREE OF COMPETITION 190
10.4.2 EUROPE: COLD PAIN THERAPY MARKET SHARE OF PLAYERS 191
FIGURE 29 EUROPE: COLD PAIN THERAPY MARKET SHARE OF TOP 3 PLAYERS (2021) 191
10.4.3 EUROPE: LIST OF KEY PLAYERS (2021) 191
10.5 COMPANY EVALUATION MATRIX 192
10.5.1 LIST OF EVALUATED VENDORS 192
10.5.2 STARS 192
10.5.3 EMERGING LEADERS 192
10.5.4 PERVASIVE PLAYERS 192
10.5.5 PARTICIPANTS 192
FIGURE 30 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 193
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021) 194
10.6.1 PROGRESSIVE COMPANIES 194
10.6.2 STARTING BLOCKS 194
10.6.3 RESPONSIVE COMPANIES 194
10.6.4 DYNAMIC COMPANIES 194
FIGURE 31 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021 195
10.7 COMPETITIVE BENCHMARKING 196
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS 196
FIGURE 32 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE COLD PAIN THERAPY MARKET 196
TABLE 213 COLD PAIN THERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 196
TABLE 214 PRODUCT FOOTPRINT OF KEY PLAYERS 197
TABLE 215 REGIONAL FOOTPRINT OF KEY PLAYERS 197
TABLE 216 COLD PAIN THERAPY MARKET: DETAILED LIST OF KEY START-UPS/SMES 197
10.8 COMPETITIVE SCENARIO 198
10.8.1 PRODUCT LAUNCHES 198
TABLE 217 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS 198
10.8.2 DEALS 198
TABLE 218 KEY DEALS 198

ページTOPに戻る

Table of Contents

Summary

The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost.
"The OTC products segment accounted for the highest growth rate in thecold pain therapymarket, by product, during the forecast period."
The cold pain therapy market is segmented into OTC products and prescription productsbased on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attributed to the easy accessibility of OTC products in retail and online pharmacies.
"E-pharmacies segment accounted for the highest CAGR."
Based on the distribution channel, the cold pain therapy market has been segmented into hospital pharmacies, retail pharmacies, and e-pharmacies. In 2021, the e-pharmaciessegment accounted for the highest growth rate. This can be attributed to the easy accessibility of medications coupled with added discounts.
"Asia Pacific: The fastest-growing regioncold pain therapymarket."
The global cold pain therapy market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as increasing geriatric population coupled with rising prevalence of arthritis and other musculoskeletal disorders.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%
Lists of Companies Profiled in the Report:

• Beiersdorf AG (Germany)
• DJO Global, Inc. (US)
• Hisamitsu Pharmaceutical Co., Inc. (Japan)
• Össur (Iceland)
• Johnson & Johnson (US)
• Pfizer (US)
• Sanofi (France)
• Rohto Pharmaceutical (Japan)
• 3M (US)
• Cardinal Health Inc. (US)
• Bird & Cronin (US)
• Compass Health Brands (US)
• Breg, Inc. (US)
• Medline Industries (US)
• Performance Health (US)
• Romsons Group of Industries (India
• Unexo Life Sciences (India)
• Polar Products (US)
• Rapid Aid (Canada)
• Mueller Sports Medicine (US)
• Pic Solution (US)
• Bruder Healthcare Company (US)
• Brownmed Inc. (US)
• Medichill (Australia)
• ThermoTek, Inc. (US)
Research Coverage:
This report provides a detailed picture of the global cold pain therapymarket. It aims at estimating the size and future growth potential of the market across different segments, such as product,application, distribution channel,and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cold pain therapy market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（通信回線）の最新刊レポート

MarketsandMarkets社の通信回線分野での最新刊レポート

本レポートと同じKEY WORD（channel）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

冷痛療法市場：製品（OTC（ゲル、クリーム、パッチ、ラップ、パッド）、処方箋（電動、非電動））、用途（筋骨格系、手術後、スポーツ障害）、流通チャネル（病院、小売、E薬局）-2027年までの世界市場予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（通信回線）の最新刊レポート

MarketsandMarkets社の通信回線分野での最新刊レポート

本レポートと同じKEY WORD（channel）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?